Anything 65 to 100 is positive news.
Because the biofloc system can't produce fish in this density that survive in the numbers they can with shmp's electrocoagulation system.
Nor can they operate it at the low cost and low manpower that SHMP'S system can do.
So either way it's a win win.
Because this system is so much more efficient and cost worthy and produces more fish per tank of the same size.
Keep all this in mind.
The Harbinger report that said the company would be worth 2.16 within a year as long as the patent proved effective said it was at 40 percent discount at modest success.
I did a little math and come up with 60/100=2.16/x giving me a best of $3.60 a share at full viability.
That isn't to say the stock wouldn't be worth much more.
the report also said, of course, that if the test proved unsuccessful completely, the company would probably go under.
And with all that in mind my theory is there will be, or may already be on the table buyout offers and that price would be dependent on the viability scale...lower or higher...because either way, this technology allows a huge company, like say a Tysons, to cut out the wholesaler and open their own farms around the country, and remove the issues with the contaminated fish coming in from the far east.
News 
Market Data 
Discover 
AI
